{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:25:41Z","timestamp":1793226341727,"version":"4.5.0"},"reference-count":23,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2007,4,29]],"date-time":"2007-04-29T00:00:00Z","timestamp":1177804800000},"content-version":"vor","delay-in-days":3466,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[1997,11]]},"abstract":"<jats:p>We evaluated the usefulness of individual tryptase levels and variations after adverse drug reactions in 64 patients. Our aim was to find a tool for the diagnosis of drug allergy. Thirty\u2010seven subjects were confirmed to have drug allergy, 12 had nonsteroidal anti\u2010inflammatory drug (NSAID) reactions, five had negative controlled drug challenges (NAAR), and 10 had symptoms after placebo intake (PLA). Serum tryptase levels greatly increased after anaphylactic shocks (2242%) and anaphylaxis (710.5%). Patients with allergic urticaria and those with idiosyncratic responses to acetylsalicylic acid (ASA) exhibited a small increase in serum tryptase (49.5% and 38.2%, respectively). In the other two groups (NAAR and PLA), no variation in this serum protease was observed. The time of appearance of the serum tryptase peak differed considerably among patients with similar clinical reactions (from 30 min to 6 h) and was independent of the latent period, severity of symptoms, or the amount of tryptase released. We conclude that serum tryptase determinations are helpful in the diagnosis of anaphylactic shock and anaphylaxis, but serial measurements may be needed to confirm mast\u2010cell participation in milder reactions.<\/jats:p>","DOI":"10.1111\/j.1398-9995.1997.tb00182.x","type":"journal-article","created":{"date-parts":[[2007,5,14]],"date-time":"2007-05-14T00:22:20Z","timestamp":1179102140000},"page":"1102-1105","source":"Crossref","is-referenced-by-count":40,"title":["Serum tryptase levels in adverse drug reactions"],"prefix":"10.1111","volume":"52","author":[{"given":"E.","family":"Ordoqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Zubeldia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Aranz\u00e1bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Tornero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. M.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Baeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,4,29]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"167","article-title":"Skin\u2010test for diagnosis of penicillin allergy current status","volume":"59","author":"Ressler CH","year":"1987","journal-title":"Ann Allergy"},{"key":"e_1_2_1_3_2","first-page":"611","volume-title":"Immunology and allergy clinics of North America","author":"Shepherd G.","year":"1991"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(05)80222-2"},{"key":"e_1_2_1_5_2","first-page":"195","volume-title":"Mechanism in asthma and rhinitis. Implications for diagnosis and treatment","author":"Nilsson G","year":"1994"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02919075"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.12.4464"},{"key":"e_1_2_1_8_2","first-page":"614","article-title":"Fixation with Carnoy's fluid reduces the number of chymase\u2010positive mast cells: not all chymase\u2010positive mast cells are also positive for tryptase","volume":"51","author":"KleinJan A","year":"1996","journal-title":"Allergy"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(91)90062-K"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.4049\/jimmunol.144.6.2304","article-title":"Immunologic and physiochemical evidence for conformational changes occurring on conversion of human mast cell tryptase from active tetramer to inactive monomer. Producing of monoclonal antibodies recognizing active tryptase","volume":"44","author":"Schwartz LB","year":"1990","journal-title":"J Immunol"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01993172"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(89)90121-8"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(90)32362-X"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1996.tb04671.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1993.tb00688.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(88)90005-X"},{"key":"e_1_2_1_17_2","first-page":"66","article-title":"Distribution of mast cell subsets in rheumatoid arthritis and osteoarthritis synovia [Abstract]","volume":"30","author":"Irani A","year":"1987","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706253162603"},{"key":"e_1_2_1_19_2","first-page":"172","article-title":"Serum tryptase levels in allergic drug reactions [Abstract]","volume":"95","author":"Ordoqui E","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000236964"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(91)90238-J"},{"key":"e_1_2_1_22_2","first-page":"83","article-title":"Determinaci\u00f3n de niveles s\u00e9ricos de triptasa en reacciones al\u00e9rgicas a medicamentos [Abstract]","volume":"9","author":"Ordoqui E","year":"1994","journal-title":"Rev Esp Alergol Inmunol Clin"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01533368"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.93.06030391"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1398-9995.1997.tb00182.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1398-9995.1997.tb00182.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T21:17:19Z","timestamp":1698441439000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1398-9995.1997.tb00182.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1997,11]]}},"alternative-id":["10.1111\/j.1398-9995.1997.tb00182.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1398-9995.1997.tb00182.x","archive":["Portico"],"relation":{},"ISSN":["0105-4538","1398-9995"],"issn-type":[{"value":"0105-4538","type":"print"},{"value":"1398-9995","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,11]]}}}